A 63-year-old with HFrEF (EF 30%) on lisinopril and furosemide remains symptomatic (NYHA II). What optimized guideline-directed therapy should be init...

Question

A 63-year-old with HFrEF (EF 30%) on lisinopril and furosemide remains symptomatic (NYHA II). What optimized guideline-directed therapy should be initiated next to reduce mortality?

Accepted Answer

Add sacubitril/valsartan in place of ACE inhibitor

Answer

Add isosorbide mononitrate

Answer

Add digoxin

Answer

Add diltiazem

Answer

Add ivabradine regardless of heart rate

us-abim MCQ (SBA): HFrEF-GDMT

A 63-year-old with HFrEF (EF 30%) on lisinopril and furosemide remains symptomatic (NYHA II). What optimized guideline-directed therapy should be initiated next to reduce mortality?